T89

· Tasly Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for T89, covering 2012-12-12 to 2025-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina [Phase 3]